South Korea
Nxera Pharma Reports Positive Phase 3 Results for Daridorexant in South Korea Insomnia Trial
Nxera Pharma; daridorexant; Phase 3; insomnia; South Korea; QUVIVIQ
Pfizer Considers Facility Sale Amid GSK’s Administrative Breach in South Korea
Pfizer, facility sale, GSK, administrative breach, South Korea, pharmaceutical industry